Skip to search formSkip to main contentSkip to account menu

Nebido

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
The goal of this study was to determine if long‐term testosterone (T) therapy in men with hypogonadism, henceforth referred to as… 
Review
2014
Review
2014
Dear Editors, Pubertal delay in males typically results from inadequate pulsatile secretion of hypothalamic gonadotrophin… 
2010
2010
INTRODUCTION Long-acting injectable testosterone undecanoate (TU, Nebido(®)), a new parenteral testosterone preparation, has… 
Highly Cited
2010
Highly Cited
2010
INTRODUCTION Low testosterone levels in men are associated with the metabolic syndrome (MetS) as well as with depressive symptoms… 
Highly Cited
2009
Highly Cited
2009
INTRODUCTION In short-term studies, testosterone replacement therapy has been shown to protect male subjects from exercise… 
2008
2008
Objective  To investigate the loading regimen for intramuscular (IM) testosterone undecanoate (Nebido®) to determine whether… 
Review
2006
Review
2006
Recently, testosterone undecanoate (TU), a new parenteral testosterone (T) preparation has been introduced. Two of its… 
Highly Cited
2006
Highly Cited
2006
INTRODUCTION Androgens are critical for maintaining penile structure and function and androgen deficiency alters the function of… 
Review
2005
Review
2005
Over the last six decades, tremendous strides have been made in the development of safe, efficacious and ‘patient-friendly…